Loading...

APC anti-mouse CD115 (CSF-1R) Antibody

Pricing & Availability
Clone
AFS98 (See other available formats)
Regulatory Status
RUO
Other Names
CSF-1R, M-CSFR, c-fms
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
A_AFS98_APC_012110
Thioglycolate-elicted BALB/c mouse peritoneal macrophages stained with CD11b FITC and AFS98 APC (top) or rat IgG2a,k APC (bottom).
  • A_AFS98_APC_012110
    Thioglycolate-elicted BALB/c mouse peritoneal macrophages stained with CD11b FITC and AFS98 APC (top) or rat IgG2a,k APC (bottom).
  • B_AFS98_APC_012110
Compare all formats See APC spectral data
Cat # Size Price Save
135509 25 µg ¥17,630
135510 100 µg ¥53,940
Description

CSF-1R, also known as CD115 and M-CSFR, is a single-pass type I membrane protein and member of the platelet-derived growth factor receptor family. This c-fms (Fms proto-oncogene) gene product's natural ligands include M-CSF and IL-34. Structural studies of CD115 have described an Ig-like extracellular domain, a transmembrane domain, an intracellular juxtamembrane domain, a split tyrosine kinase domain, and a C-terminal tail receptor. Receptor activation induces homodimerization in addition to phosphorylation and ubiquitination of intracellular residues. CD115 directly influences tissue macrophage and osteoclast differentiation and proliferation. It is expressed on monocytes/macrophages, peritoneal exudate cells, plasmacytoid and conventional dendritic cells, and osteoclasts.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of ligand binding1. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays.

It has been reported that CD115 can be rapidly internalized, especially when samples are exposed to room temperature. Approximate 33% decrease in CD115 expression has been observed between 0 and 4 hours after sample collection, while overnight incubation of the cells results in complete CD115 downregulation. Pre-treatment with EDTA and low temperatures (2 to 8°C) helps in maintaining surface expression of CD1154.

Application References

(PubMed link indicates BioLegend citation)
  1. Sudo T, et al. 1995. Oncogene 11:2469.
  2. Murayama T, et al. 1999. Circulation 99:1740.
  3. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. PubMed
  4. Breslin WL, et al. 2013. J Immunol Methods. 390(1-2):1 PubMed
  5. Dong L, et al. 2016. Nature. 539:304–308. PubMed
Product Citations
  1. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  2. McNamara NB, et al. 2023. Nature. 613:120. PubMed
  3. Tunali G, et al. 2023. J Clin Invest. :. PubMed
  4. Gupta T, et al. 2023. Front Immunol. 14:1044703. PubMed
  5. Hu S, et al. 2018. Front Immunol. 9:01. PubMed
  6. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  7. Andrés-Blasco I, et al. 2015. J Endocrinol. 227: 179 - 191. PubMed
  8. Hickey A, et al. 2021. Front Microbiol. 12:653587. PubMed
  9. Accarias S, et al. 2020. J Cell Sci. 133:. PubMed
  10. Mason HD, et al. 2021. JCI Insight. 6:e149229. PubMed
  11. Kobori T, et al. 2018. Front Immunol. 9:334. PubMed
  12. Fujii Y, et al. 2022. JBMR Plus. 6:e10562. PubMed
  13. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  14. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  15. Hong H, et al. 2013. Biochem Biophys Res Commun. 440:545. PubMed
  16. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  17. Pedragosa J, et al. 2020. J Cereb Blood Flow Metab. 40:S98. PubMed
  18. Svahn S, et al. 2015. Infect Immun . 83:514. PubMed
  19. Izquierdo-Useros N, et al. 2014. J Immunol . 192:4852-4858. PubMed
  20. Shami A, et al. 2015. Sci Rep. 5: 13904. PubMed
  21. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  22. Saulnier N, et al. 2013. PLoS One. 7:30788. PubMed
  23. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  24. Herrero–Cervera A, et al. 2019. Diabetologia. 62:2143. PubMed
  25. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  26. Sauter K, et al. 2014. J Leukoc Biol. 96:265. PubMed
  27. Svahn S, et al. 2016. Infect Immun . 84: 1205-1213. PubMed
  28. Wang X, et al. 2016. J Immunol. 197(12):4750-4761. PubMed
  29. Keerthivasan S, et al. 2021. Immunity. 54(7):1511-1526.e8. PubMed
  30. Ledo JH, et al. 2020. PLoS One. e0237773:15. PubMed
  31. Kitamura K, et al. 2019. Int J Cardiol Heart Vasc. 23:100344. PubMed
  32. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  33. Baratin M, et al. 2017. Immunity. 47:349. PubMed
  34. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  35. Asada S, et al. 2018. Nat Commun. 9:2733. PubMed
  36. Theurich S et al. 2017. Cell metabolism. 26(1):171-184 . PubMed
  37. Viaud M, et al. 2020. Cell Reports. 30(10):3397-3410. PubMed
  38. Tähtinen S, et al. 2022. Nat Immunol. 23:532. PubMed
  39. Patel C, et al. 2022. Curr Protoc. 2:e400. PubMed
  40. Reed-Geaghan EG, et al. 2020. J Exp Med. 217:00:00. PubMed
  41. Fransén Pettersson N, et al. 2018. PLoS One. 13:e0203228. PubMed
  42. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  43. Kwok I, et al. 2020. Immunity. 53(2):303-318.e5. PubMed
  44. Park SM et al. 2018. Cell stem cell. 24(1):153-165 . PubMed
  45. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  46. Buschor S, et al. 2017. PLoS Pathogens. 13(6):e1006476. PubMed
  47. Cleary MM, et al. 2021. Mol Cancer Ther. 20:906. PubMed
  48. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  49. Ledo JH, et al. 2020. Mol Psychiatry. . PubMed
RRID
AB_2085221 (BioLegend Cat. No. 135509)
AB_2085221 (BioLegend Cat. No. 135510)

Antigen Details

Structure
Ig superfamily, 145 kD
Distribution

Monocytes/macrophages, peritoneal exudate cells, plasmacytoid and conventional dendritic cells, osteoclasts

Function
Growth factor receptor, tyrosine kinase
Ligand/Receptor
Macrophage colony stimulating factor (M-CSF), IL-34
Cell Type
Dendritic cells, Macrophages, Monocytes, Osteoclasts
Biology Area
Immunology
Molecular Family
CD Molecules, Cytokine/Chemokine Receptors
Antigen References
  1. Sudo T, et al. 1995 Oncogene 11:2469.
  2. Murayama T, et al. 1999 Circulation 99:1740.
  3. Goswami S, et al. 2005 Cancer Res. 65:5278.
  4. Yu W, et al. 2008 J. Leuko. Biol. 84:852.
Gene ID
12978 View all products for this Gene ID
UniProt
View information about CD115 on UniProt.org

Related FAQs

Why do I have a weak CD115 staining?

It has been reported that CD115 can be rapidly internalized, especially when samples are exposed to room temperature. Approximate 33% decrease in CD115 expression has been observed between 0 and 4 hours after sample collection, while overnight incubation of the cells results in complete CD115 downregulation.  Pre-treatment with EDTA and low temperatures (2 - 8°C) helps in maintaining surface expression of CD115. In addition, brief fixation of the cells with Fixation Buffer (Cat. No. 420801) for 10 minutes will block CD115 internalization.

Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account